RxDoctor Payments DataLook up a doctor →

Edwin Robinson, MD

Family Medicine · Richmond, VANPI 1306841564

Payments from drug & device makers

$83,244in general payments, 2019–2025

Across 644 payments — averaging $129.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$71K
  • AstraZeneca$2K
  • AbbVie$1K
  • Amgen$981
  • Novo Nordisk$868
  • Lilly USA, LLC$812
  • plus $6K from 54 others

What the payments were for

  • Consulting fees$70,96785%
  • Travel & lodging$2440%
  • Food & beverage$12,02814%
  • Education$60%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis146$71,289
AstraZeneca40$2,243
AbbVie(2 entities)51$1,480
Amgen68$981
Novo Nordisk46$868
Lilly USA, LLC46$812
Phathom Pharmaceuticals, Inc.13$511
Pfizer31$457
Abbott16$377
Boehringer Ingelheim20$373
GSK10$317
Corium, LLC13$294
Takeda Pharmaceuticals U.S.A., Inc.24$282
Esperion Therapeutics, Inc.9$266
Johnson & Johnson(2 entities)6$227
Sumitomo Pharma America, Inc.8$222
Eisai Inc.3$151
Axsome Therapeutics, Inc.3$141
Amarin Pharma, Inc.4$131
Xeris Pharmaceuticals, Inc.6$118
Irhythm Technologies, Inc.2$113
Cequr Corporation1$109
Merck7$99
Lundbeck LLC6$97
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$96
Biohaven Pharmaceuticals, Inc.1$94
Teva Pharmaceuticals USA, Inc.6$90
Tris Pharma Inc1$84
Idorsia Pharmaceuticals US Inc2$81
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$79
E.r. Squibb & Sons, L.L.C.4$51
Biohaven Pharmaceutical Holding Company Ltd.2$50
Sunovion Pharmaceuticals Inc.3$47
Genentech USA, Inc.3$45
Ardelyx, Inc.2$36
Kowa Pharmaceuticals America, Inc.2$30
Sanofi-aventis U.S. LLC2$29
ARS Pharmaceuticals Operations, Inc.1$23
Endo Pharmaceuticals Inc.1$23
Dexcom, Inc.1$21
Seqirus USA Inc1$21
Tolmar, Inc.1$21
Exact Sciences1$20
Otsuka America Pharmaceutical, Inc.1$20
Azurity Pharmaceuticals, Inc.1$20
Ironwood Pharmaceuticals, Inc1$20
Endo USA, Inc.1$20
Vanda Pharmaceuticals Inc.1$19
Gilead1$19
Kaleo, Inc.1$19
Regeneron Healthcare Solutions, Inc.1$18
Viatris Specialty LLC1$17
Astellas Pharma US Inc1$17
Sandoz1$17
Shield Therapeutics Inc1$17
Abiomed1$16
IBSA Pharma Inc.1$14
Edwards Lifesciences1$14
Sanofi Pasteur Inc.1$14
Bausch Health US, LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,244 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$107,059
Medicare patients
890
Services billed
2,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav113$1,005
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort13$794
Prednisone107$751
Albuterol Sulfate HfaAlbuterol Sulfate39$729
Azithromycin153$593
Oseltamivir Phosphate19$397
Amoxicillin108$394
Methylprednisolone71$383
Sulfacetamide Sodium12$362
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst40$332
Doxycycline Hyclate41$314
Triamcinolone Acetonide30$288
Ciprofloxacin Hcl48$279
Cephalexin56$204
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim44$145

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$457$031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →